louisiana glp-1 intestinal paralysis class action Ozempic Lawsuit Louisiana Ozempic Lawyer | Injury
Description
Obesity and diabetic kidney disease
Newer incretin-based medications like semaglutide and tirzepatide have changed obesity treatment by producing substantial weight loss, but their effects on neuropsychiatric health remain uncertain in routine clinical practice
2017, doi: 10.1016/S2213-8587(17)30013-X
A patient with low GLP1R activity may achieve better results with tirzepatide (which recruits the GIP axis) than semaglutide alone
